DR Horton Filter Stocks by Fundamentals
| DHI Stock | USD 147.63 1.66 1.14% |
| = | null |
Institutional Holders
The institutional ownership of DR Horton reflects the concentration of DR Horton's shares among large entities. Because these investors hold large blocks of stock, they can meaningfully influence DR Horton's corporate direction. Rising institutional ownership in DR Horton may signal growing confidence among professional money managers.| Shares | Greenhaven Associates Inc | 2026-03-31 | 3.5 M | Dimensional Fund Advisors, Inc. | 2025-12-31 | 3.1 M | Bank Of America Corp | 2025-12-31 | 2.9 M | Northern Trust Corp | 2025-12-31 | 2.9 M | The Goldman Sachs Group Inc | 2025-12-31 | 2.9 M | Franklin Resources Inc | 2025-12-31 | 2.6 M | Aqr Capital Management Llc | 2025-12-31 | 2.5 M | Principal Financial Group Inc | 2025-12-31 | 2.1 M | Charles Schwab Investment Management Inc | 2025-12-31 | 2 M | Capital World Investors | 2025-12-31 | 36.9 M | Vanguard Group Inc | 2025-12-31 | 32.7 M |
Important Fundamentals
| Return On Equity TTM | 0.13 | |||
| Return On Asset TTM | 0.073 | |||
| Profit Margin TTM | 0.0951 | |||
| Operating Margin TTM | 0.11 | |||
| Current Valuation | 46.25 B | |||
| Shares Outstanding | 283.58 M | |||
| Shares Owned By Insiders | 11.57 % | |||
| Shares Owned By Institutions | 89.69 % | |||
| Number Of Shares Shorted | 15.42 M | |||
| Price To Earnings TTM | 5.10 X | |||
| Price To Book TTM | 1.76 X | |||
| Price To Sales TTM | 1.26 X | |||
| Revenue TTM | 34.25 B | |||
| Gross Profit TTM | 7.2 B | |||
| EBITDA TTM | 4.84 B | |||
| Net Income TTM | 3.59 B | |||
| Cash And Equivalents TTM | 2.99 B | |||
| Cash Per Share TTM | 7.08 X | |||
| Total Debt TTM | 6.03 B | |||
| Debt To Equity TTM | 0.31 % | |||
| Current Ratio TTM | 5.24 X | |||
| Book Value Per Share TTM | 82.92 X | |||
| Cash Flow From Operations TTM | 3.42 B | |||
| Short Ratio TTM | 5.55 X | |||
| Earnings Per Share | 10.64 X | |||
| Price To Earnings To Growth | 1.37 X | |||
| Target Price | 165.29 | |||
| Number Of Employees | 14.34 K | |||
| Trailing Beta | 1.41 | |||
| Market Capitalization TTM | 41.86 B | |||
| Total Asset TTM | 35.47 B | |||
| Retained Earnings TTM | 31.04 B | |||
| Working Capital TTM | 32.18 B | |||
| Current Asset TTM | 9.78 B | |||
| Current Liabilities TTM | 849.2 M | |||
| Annual Yield | 0.0122 | |||
| Five Year Return | 1.11 % | |||
| Net Asset | 35.47 B | |||
| Last Dividend Paid | 1.7 |
Financial Metrics, Fundamentals & Methodology
DR Horton's operating framework helps explain margin behavior, earnings persistence, and funding capacity. Debt exposure shapes how much financial pressure DR Horton could face in weaker periods. Latest reported fundamentals for DR Horton include revenue of 34.25 billion, positive EPS of 10.64, operating margin of 11.26%, current ratio of 5.24 as of the latest reporting period.
DR Horton metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Analyst projections are included when active coverage applies. Accounting-line values follow GAAP or IFRS structures as published in issuer filings.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board